Dosidal · Switzerland

Boostrix, Injektionssuspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:637 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 637
atc: J07AJ52
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2000-08-10
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J07AJ52
authorisation_number: 637
form: SUPA
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 08.08.
name: Boostrix, Injektionssuspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
Br5meA6fN5Uy3v4KQG6BsdBUjgHBM1gcyGdvFr5BLi6nr7KN4LE93nWhBUQr-JVfv9QOHYwLN9T4SXMAo9LmSA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:637 · Related records in other markets · Dosidal